Coty (COTY) reported $1.3 billion in revenue for the quarter ended March 2025, representing a year-over-year decline of 6.2%. EPS of $0.01 for the same period compares to $0.05 a year ago.The reported revenue represents a surprise of -0.43% over the Zacks Consensus Estimate of $1.3 billion. With the consensus EPS estimate being $0.05, the EPS surprise was -80.00%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next ...

Core Insights - Vimeo, Inc. reported revenue of $103.03 million for Q1 2025, a year-over-year decline of 1.8% and an EPS of -$0.02 compared to $0.04 a year ago, with a revenue surprise of +1.66% over the Zacks Consensus Estimate of $101.36 million and an EPS surprise of +33.33% [1] Financial Performance - The company’s revenue metrics show that Vimeo Enterprise generated $24.42 million, exceeding the average estimate of $24.29 million, representing a year-over-year increase of +32.3% [4] - Self-Serve & Add-Ons revenue was reported at $64.69 million, slightly above the average estimate of $63.07 million, but this reflects a year-over-year decline of -7.5% [4] - The Average Revenue Per User (ARPU) for Vimeo Enterprise was $24,624, surpassing the estimated $23,397.16, while the ARPU for Self-Serve & Add-Ons was $189, below the estimated $209.53 [4] Stock Performance - Vimeo shares have returned +7.8% over the past month, outperforming the Zacks S&P 500 composite, which saw a change of +0.4% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]

江苏华昌化工股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、 误导性陈述或重大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息 的真实、准确、完整。 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002274 证券简称：华昌化工 公告编号：2025-012 3.第一季度报告是否经审计 □是 √否 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 √否 ■ （二） 非经常性损益项目和金额 √适用 □不适用 单位：元 ■ 其他符合非经常性损益定义的损益项目的具体情况 □适用 √不适用 公司不存在其他符合非经常性损益定义的损益项目的具体情况。 将《公开发行证券的公司信息披露解释性公告第1号一一非经常性损益》中列举的非经常性损益项目界 定为经常性损益项目的情况说明 □适用 √不适用 公司不存在将《公开发行证 ...

Core Viewpoint - Take-Two Interactive's stock experienced significant volatility following the announcement of the delay in the release of the highly anticipated game, GTA 6, which is now scheduled for May 26 next year [1][3] Group 1: Stock Performance - The company's stock price fell sharply after opening, dropping from a closing price of 235.17 to approximately 211, marking a decline of over 10% [1] - Despite a subsequent rebound, the stock remained within a range of 7% to 9% decline [1] Group 2: Impact of GTA 6 Delay - The delay of GTA 6 means it will not contribute to Take-Two's revenue plans for the current fiscal year, which ends on March 31, 2026 [1] - This postponement poses challenges for the company's financial planning [1] Group 3: CEO's Optimism and Future Plans - CEO Strauss Zelnick expressed confidence in achieving record net bookings in fiscal year 2026 and setting new highs in fiscal year 2027, despite the impact of the delay [3] - The company prioritizes product quality, which led to the decision to postpone GTA 6 [3] - Take-Two plans to release several other major titles this year, including the early release of Borderlands 4 on September 12, ahead of the original date of September 23 [3]

Moderna (MRNA) reported $108 million in revenue for the quarter ended March 2025, representing a year-over-year decline of 35.3%. EPS of -$2.52 for the same period compares to -$3.07 a year ago.The reported revenue represents a surprise of -14.95% over the Zacks Consensus Estimate of $126.98 million. With the consensus EPS estimate being -$2.92, the EPS surprise was +13.70%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine ...

Group 1 - The company reported adjusted earnings per share of €1.57 for the first quarter, exceeding the estimate of €1.38 [1] - First quarter sales amounted to €17.4 billion, slightly below the forecast of €17.6 billion [1] - Adjusted EBITDA for the first quarter was €2.63 billion, surpassing the expected €2.61 billion [2] Group 2 - The company anticipates an adjusted EBITDA for the full year ranging from €8.0 billion to €8.4 billion [3]

Core Insights - Columbia Sportswear reported revenue of $778.45 million for the quarter ended March 2025, reflecting a year-over-year increase of 1.1% and a surprise of +2.49% over the Zacks Consensus Estimate of $759.57 million [1] - The company's EPS for the same period was $0.75, compared to $0.71 a year ago, resulting in an EPS surprise of +10.29% against the consensus estimate of $0.68 [1] Financial Performance - The stock has returned -19.6% over the past month, contrasting with the Zacks S&P 500 composite's -0.7% change, indicating underperformance relative to the broader market [3] - Columbia Sportswear holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the market in the near term [3] Geographic Sales Breakdown - United States: Net sales of $471.18 million, exceeding the two-analyst average estimate of $465.92 million, but showing a year-over-year decline of -0.7% [4] - Canada: Net sales of $47.58 million, below the average estimate of $49.51 million, with a year-over-year change of -9.2% [4] - EMEA: Net sales of $107.48 million, surpassing the estimated $103.98 million, representing a +2.9% year-over-year increase [4] - LAAP: Net sales of $152.21 million, exceeding the average estimate of $141.39 million, with a year-over-year change of +9.7% [4]

Core Insights - Cullen/Frost Bankers (CFR) reported revenue of $560.42 million for Q1 2025, a year-over-year increase of 7.2% and exceeding the Zacks Consensus Estimate of $550.38 million by 1.82% [1] - The earnings per share (EPS) for the same quarter was $2.30, up from $2.15 a year ago, and also surpassed the consensus EPS estimate of $2.17 by 5.99% [1] Financial Metrics - Net loan charge-offs to average loans were 0.2%, better than the estimated 0.3% [4] - Total earning assets averaged $47.42 billion, slightly below the average estimate of $47.91 billion [4] - Net Interest Margin (FTE) was reported at 3.6%, matching the three-analyst average estimate [4] - Total Non-Performing Loans were $83.53 million, higher than the average estimate of $79.87 million [4] - Book value per common share at the end of the quarter was $61.74, exceeding the estimated $60.28 [4] - Total Non-Interest Income reached $124.01 million, surpassing the average estimate of $117.23 million [4] - Net Interest Income (FTE) was $436.40 million, slightly above the average estimate of $433.15 million [4] - Service charges on deposit accounts totaled $28.62 million, exceeding the estimated $26.79 million [4] - Net Interest Income was reported at $416.22 million, below the average estimate of $417.56 million [4] - Insurance commissions and fees were $21.02 million, higher than the estimated $18.29 million [4] - Trust and investment management fees reached $42.93 million, exceeding the average estimate of $41.20 million [4] - Other charges, commissions, and fees totaled $13.59 million, slightly above the estimated $13.38 million [4] Stock Performance - Shares of Cullen/Frost have returned -6.6% over the past month, compared to the Zacks S&P 500 composite's -0.7% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

CVS Health (CVS) reported $94.59 billion in revenue for the quarter ended March 2025, representing a year-over-year increase of 7%. EPS of $2.25 for the same period compares to $1.31 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $92.95 billion, representing a surprise of +1.76%. The company delivered an EPS surprise of +31.58%, with the consensus EPS estimate being $1.71.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street ...

Core Insights - Axis Capital reported revenue of $1.55 billion for the quarter ended March 2025, reflecting an 8.3% increase year-over-year, but fell short of the Zacks Consensus Estimate of $1.65 billion by -5.92% [1] - The company's EPS was $3.17, up from $2.57 in the same quarter last year, exceeding the consensus EPS estimate of $2.64 by +20.08% [1] Financial Performance Metrics - The combined ratio for insurance was 86.7%, slightly better than the estimated 86.9% [4] - The net loss and loss expense ratio totaled 58.6%, outperforming the estimated 61.1% [4] - The total combined ratio was 90.2%, compared to the average estimate of 93.5% [4] - The acquisition cost ratio for insurance was 19.2%, above the estimated 18.2% [4] - General and administrative expense ratio for total was 9.8%, significantly lower than the estimated 12.7% [4] - Net investment income reached $207.71 million, surpassing the average estimate of $188.03 million, marking a +24.1% year-over-year increase [4] - Net premiums earned were $1.34 billion, below the estimated $1.42 billion, but showed a +6.6% change year-over-year [4] - Other insurance-related income was $3.58 million, significantly lower than the estimated $7.17 million, representing a -57.1% year-over-year decline [4] - Net premiums earned in the insurance segment were $1.01 billion, slightly below the estimated $1.04 billion, with a +10% year-over-year change [4] - Net premiums earned in the reinsurance segment were $330.73 million, below the estimated $366.10 million, reflecting a -2.8% year-over-year change [4] Stock Performance - Axis Capital's shares have returned -3.7% over the past month, compared to a -0.2% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 2 (Buy), indicating potential for outperformance in the near term [3]